| BBIO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BBIO shares outstanding history going back to 6/27/2019:
Also see: BBIO Market Cap History BBIO YTD Return |

| BBIO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BBIO shares outstanding history going back to 6/27/2019:
Also see: BBIO Market Cap History BBIO YTD Return |
| BBIO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BBIO Historical Shares Outstanding: +8.19% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BBIO Stock Price Chart |
| About BridgeBio Pharma Inc |
| BridgeBio Pharma, Inc. is a commercial-stage biopharmaceutical company focused on developing transformative medicines for genetic diseases and cancers with clear genetic drivers. Its pipeline includes Acoramidis (AG10) for amyloidosis TTR (ATTR), low-dose infigratinib for achondroplasia, Encaleret for Autosomal Dominant Hypocalcemia Type 1 (ADH1), and BBP-418 for LGMD2I (LGMDR9). The company's programs range from early science to advanced clinical trials, aiming to discover, create, test, and deliver these treatments to patients. We show 28 historical shares outstanding datapoints in our coverage of BBIO's shares outstanding history. Understanding the changing numbers of BBIO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BBIO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BBIO by allowing them to research BBIO shares outstanding history as well as any other stock in our coverage universe. |
| BBIO Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| BBIO Share Performance |
| Shares Outstanding Peers |
| BridgeBio Pharma (BBIO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
BBLG Shares Outstanding History BCAB Shares Outstanding History BCDA Shares Outstanding History BCEL Shares Outstanding History BCLI Shares Outstanding History BCRX Shares Outstanding History BDSI Shares Outstanding History BDSX Shares Outstanding History BDTX Shares Outstanding History BDX Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.